These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1241899)

  • 1. The dosage of co-trimoxazole in childhood.
    Fowle AS; Bye A; Hariri F; Middlemiss D; Naficy K
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):217-22. PubMed ID: 1241899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of trimethoprim and sulfonamide after administration of trimethoprim-sulfamethoxazole and trimethoprim-sulfamoxole.
    Gupta KC; Desai NK; Paul T; Sheth UK
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):536-7. PubMed ID: 7228448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of trimethoprim-sulfamethoxazole in children.
    Wilfert CM; Gutman LT
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):73-6. PubMed ID: 1093656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of trimethoprim-sulfamethoxazole in blood after a single, large oral dose.
    Yoshikawa TT; Guze LB
    Antimicrob Agents Chemother; 1976 Sep; 10(3):462-3. PubMed ID: 984788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole.
    Grose WE; Bodey GP; Loo TL
    Antimicrob Agents Chemother; 1979 Mar; 15(3):447-51. PubMed ID: 464572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biseptol dosage in children in relation to the degree of renal failure and body weight. II].
    Sieniawska M; Wróblewska-Kałuzewska M; Białasik D; Korniszewska J; Wierzbowska-Lange B; Wierzba K
    Pediatr Pol; 1984 Mar; 59(3):189-96. PubMed ID: 6610854
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of trimethoprim-sulfamethoxazole in newborn infants.
    Springer C; Eyal F; Michel J
    J Pediatr; 1982 Apr; 100(4):647-50. PubMed ID: 7062219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of slow infusions of co-trimoxazole by using predictive pharmacokinetics.
    Morgan DJ; Raymond K
    Antimicrob Agents Chemother; 1980 Feb; 17(2):132-7. PubMed ID: 7387137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: clinical aspects.
    Smellie JM; Grüneberg RN; Leakey A; Atkin WS
    Br Med J; 1976 Jul; 2(6029):203-6. PubMed ID: 974492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of trimethoprim and sulphamethoxazole in the human prostate gland after intramuscular injection.
    Wright WL; Larking P; Lovell-Smith CJ
    Br J Urol; 1982 Oct; 54(5):550-1. PubMed ID: 6983378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of co-trimazine once daily and co-trimoxazole twice daily in treatment of urinary tract infections in children.
    Adam D; Hager C; Dorn G; Bamberg P
    J Antimicrob Chemother; 1982 Nov; 10(5):453-8. PubMed ID: 6983524
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of concentrations of trimethoprim-sulphamethoxazole in the human prostate gland.
    Dabhoiwala NF; Bye A; Claridge M
    Br J Urol; 1976 Feb; 48(1):77-81. PubMed ID: 1268470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative trial of oral chloroquine and oral co-trimoxazole in vivax malaria in children.
    Lal H
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):438-40. PubMed ID: 7044160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relative bioavailability of co-trimoxazole suspensions].
    Günther C; Truckenbrodt J; Traeger A
    Pharmazie; 1987 Jun; 42(6):397-9. PubMed ID: 3499619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum concentration of Co-trimeoxazole in various galenic preparations].
    Windorfer A; Daschner F
    MMW Munch Med Wochenschr; 1977 Nov; 119(45):1475-6. PubMed ID: 412097
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of pectin and kaolin on bioavailability of co-trimoxazole suspension.
    Gupta KC; Desai NK; Satoskar RS; Gupta C; Goswami SN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):320-1. PubMed ID: 3497885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.
    Ortengren B; Magni L; Bergan T
    Infection; 1979; 7 Suppl 4():S371-81. PubMed ID: 511351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of sulfamethoxazole and trimethoprim association in hens.
    Queralt J; Castells I
    Poult Sci; 1985 Dec; 64(12):2362-7. PubMed ID: 4095069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal somatic growth in children receiving low-dose prophylactic co-trimoxazole.
    Smellie JM; Preece MA; Paton AM
    Eur J Pediatr; 1983 Sep; 140(4):301-4. PubMed ID: 6605250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.